Author

Pu You

Zhangjiang Laboratory

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Bing CaiiD· 2 shared Jing PaniD· 2 shared Liang Chen· 2 shared Ying Qing MaoiD· 2 shared Bojie Yang· 1 shared Haibo WangiD· 1 shared Haixiang Shi· 1 shared Hao Luo· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Bing CaiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The DDIT4L-TOM40-ATP5A pathway suppresses glioblastoma oncogenesis

Pu You, Zeng-Xin Qi, Hao Luo, Bing Cai, Xuye Hu, Jing Pan, P. Gan, Xin-Ying Zeng, Ri-Jing Liao, Qisheng Tang, Ye Yu, Zhen-Ning Zhang, Bojie Yang, Liang Chen, Xu Zhang, , Ying Mao

This study identifies DDIT4L as an inhibitor of glioblastoma by suppressing mitochondrial function and inducing apoptosis, with a synthetic peptide showing therapeutic potential.

Genes & Diseases · Mar 4, 2026Peer-reviewedCancer Biology

Human DDIT4L intron retention contributes to cognitive impairment and amyloid plaque formation.

Kaicheng Li, Haixiang Shi, Zhen Li, Pu You, Jing Pan, Yi-Chuan Cai, Jin-Wen Li, Xue-Fei Ma, Shuo Zhang, Lei Diao, Bing Cai, Yang Lu, Haibo Wang, Ying Qing Mao, Liang Chen, Xu Zhang

This study identifies DDIT4L intron retention (DIR) as a contributor to cognitive impairment and amyloid plaque formation in Alzheimer's disease through interactions with gelsolin and GluA1.

Cell Discovery · Feb 10, 2025Peer-reviewedNeuroscience